Several articles have provided constructive insights into the development and treatment of BC based on the immune genes and the TME [48–50], and the existence of a close association between JAM3 and a variety of immune cells suggests to us that there exists a certain correlation between JAM3 and the immune microenvironment of BC, which we believe can be further elucidated in the future studies. This evidence concerns the gene JAM3 and breast cancer.